 | | PRD_001184 | | Name: | Dimethyl FK228 | | Formula: | C26 H42 N4 O6 S2 | | Description: | DIMETHYL FK228 IS THE REDUCED AND MODIFIED FORM OF ROMIDEPSIN. THE DISULFIDE INTRAMOLECULAR LINKAGE OF ROMIDEPSIN IS BROKEN, AND BOTH SULFHYDRYL GROUPS ARE METHYLATED. | | Definition date: | 2014-03-05 | | Last modified: | 2023-11-03 |
|
 | | PRD_001189 | | Name: | ATSP-7041 stapled-peptide | | Formula: | C87 H124 N16 O22 | | Definition date: | 2013-11-20 | | Last modified: | 2023-11-03 |
|
 | | PRD_001198 | | Name: |
(3aR,5aS,8S,10aS)-1-[(3S,6R,8aS)-1'-[(2S)-2-acetamido-3-(2-chlorophenyl)propanoyl]-5-oxidanylidene-spiro[1,2,3,8a-tetrahydroindolizine-6,2'-pyrrolidine]-3-yl]carbonyl-10-oxidanylidene-2,3,3a,5a,8,10a-hexahydrodipyrrolo[3,2-b:3',1'-f]azepine-8-carboxylic acid | | Formula: | C35 H38 Cl N5 O7 | | Definition date: | 2014-10-15 | | Last modified: | 2023-11-03 |
|
 | | PRD_001201 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-leucinamide | | Formula: | C29 H49 N3 O6 | | Definition date: | 2014-02-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001215 | | Name: | Macrocyclic Inhibitor (3R,6S,9S,12E,16S)-9-(3-AMINO-3-OXO-PROPYL)-3-[(4-BENZOYLPHENYL)METHYL]-6-(CYCLOHEXYLMETHYL)-2,5,8,11,14-PENTAOXO-1,4,7,10,15-PENTAZACYCLOICOS-12-ENE-16-CARBOXAMIDE | | Formula: | C40 H48 N7 O9 | | Definition date: | 2014-05-21 | | Last modified: | 2023-11-03 |
|
 | | PRD_000428 | | Name: | CYCLOTHEONAMIDE A | | Formula: | C36 H46 N9 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000456 | | Formula: | C39 H67 N12 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001233 | | Name: | cyclic-tris-phenylselenazole | | Formula: | C36 H30 N6 O3 Se3 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_000464 | | Name: | Argadin | | Formula: | C29 H41 N10 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_001234 | | Name: | cyclic-tris-leucylselenazole | | Formula: | C27 H36 N6 O3 Se3 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_001235 | | Name: | cyclic-tris-valinylselenazole | | Formula: | C24 H30 N6 O3 Se3 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_001236 | | Name: | cyclic-tris-alanylselenazole | | Formula: | C18 H18 N6 O3 Se3 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_001237 | | Name: | Boc-Ala-Ala-Ala-Al-CHO | | Formula: | C14 H27 N3 O5 | | Definition date: | 2014-06-18 | | Last modified: | 2023-11-03 |
|
 | | PRD_001243 | | Name: | N-{(2S)-2-[(morpholin-4-ylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-N-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-L-phenylalaninamide | | Formula: | C40 H61 N5 O7 | | Definition date: | 2015-02-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_001255 | | Name: | Promothiocin A | | Formula: | C36 H47 N11 O8 S2 | | Definition date: | 2014-12-10 | | Last modified: | 2023-11-03 |
|
 | | PRD_000553 | | Name: | APSTATIN | | Formula: | C23 H33 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000554 | | Name: | Cyclotheonamide A | | Formula: | C36 H46 N9 O8 | | Definition date: | 2012-02-03 | | Last modified: | 2023-11-03 |
|
 | | PRD_000555 | | Name: | AERUGINOSIN 298-A | | Formula: | C30 H48 N6 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000561 | | Name: | FR901277 | | Formula: | C47 H63 N9 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002098 | | Formula: | C29 H43 N10 O9 | | Definition date: | 2013-08-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_002103 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-1-{[(1R)-1-carboxybutyl]amino}-2-hydroxy-5-methylhexan-3-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C30 H51 N5 O8 S | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002107 | | Name: | L-alpha-glutamyl-L-isoleucyl-N-[(2S,3S)-4-{[(1S)-1-carboxybutyl]amino}-3-hydroxy-1-(thiophen-2-yl)butan-2-yl]-3-thiophen-2-yl-L-alaninamide | | Formula: | C31 H47 N5 O8 S2 | | Definition date: | 2015-07-01 | | Last modified: | 2023-11-03 |
|
 | | PRD_002111 | | Name: | 3,5-difluoro-Nalpha-[(2E,5S)-5-methylhept-2-enoyl]-N-[(2S,6aS,12S,13R,15aS,21S,23aS)-2,13,21-trimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-L-phenylalaninamide | | Formula: | C41 H56 F2 N6 O8 | | Definition date: | 2014-10-08 | | Last modified: | 2023-11-03 |
|
 | | PRD_002126 | | Name: | N-[4-(benzoylamino)butanoyl]-3-(8-phenyloctyl)-L-histidyl-L-seryl-O-phosphono-L-allothreoninamide | | Formula: | C38 H54 N7 O10 P | | Definition date: | 2014-12-03 | | Last modified: | 2023-11-03 |
|
 | | PRD_002132 | | Name: | (10S,13S,16S,19S)-16-benzyl-12-(N-methyl-L-alanyl-L-valyl)-3,14,17-trioxo-2,7,8,9,12,15,18-heptaazatetracyclo[19.2.2.1~6,9~.1~10,13~]heptacosa-1(23),6(27),7,21,24-pentaene-19-carboxylic acid | | Formula: | C37 H47 N9 O7 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
